• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载药介孔硅纳米颗粒通过调控 MDSCs 增强抗肿瘤免疫治疗。

Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs.

机构信息

Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Function Materials and Devices, Soochow University, Suzhou 215123, China.

出版信息

Molecules. 2024 May 22;29(11):2436. doi: 10.3390/molecules29112436.

DOI:10.3390/molecules29112436
PMID:38893313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11173511/
Abstract

Myeloid-derived suppressor cells (MDSCs) are recognized as major immune suppressor cells in the tumor microenvironment that may inhibit immune checkpoint blockade (ICB) therapy. Here, we developed a Stattic-loaded mesoporous silica nanoparticle (PEG-MSN-Stattic) delivery system to tumor sites to reduce the number of MDSCs in tumors. This approach is able to significantly deplete intratumoral MSDCs and thereby increase the infiltration of T lymphocytes in tumors to enhance ICB therapy. Our approach may provide a drug delivery strategy for regulating the tumor microenvironment and enhancing cancer immunotherapy efficacy.

摘要

髓系来源的抑制性细胞(MDSCs)被认为是肿瘤微环境中的主要免疫抑制细胞,可能会抑制免疫检查点阻断(ICB)治疗。在这里,我们开发了一种负载 Stattic 的介孔硅纳米粒子(PEG-MSN-Stattic)递药系统,将其递送至肿瘤部位,以减少肿瘤中的 MDSC 数量。该方法能够显著耗竭肿瘤内的 MDSC,从而增加肿瘤内 T 淋巴细胞的浸润,增强 ICB 治疗效果。我们的方法可能为调节肿瘤微环境和增强癌症免疫治疗效果提供了一种药物递送策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fca7/11173511/0adf093db03d/molecules-29-02436-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fca7/11173511/f3a60701da4c/molecules-29-02436-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fca7/11173511/67a197404f86/molecules-29-02436-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fca7/11173511/c97f1e7e2524/molecules-29-02436-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fca7/11173511/e962aca727ac/molecules-29-02436-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fca7/11173511/0adf093db03d/molecules-29-02436-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fca7/11173511/f3a60701da4c/molecules-29-02436-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fca7/11173511/67a197404f86/molecules-29-02436-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fca7/11173511/c97f1e7e2524/molecules-29-02436-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fca7/11173511/e962aca727ac/molecules-29-02436-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fca7/11173511/0adf093db03d/molecules-29-02436-g005.jpg

相似文献

1
Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs.载药介孔硅纳米颗粒通过调控 MDSCs 增强抗肿瘤免疫治疗。
Molecules. 2024 May 22;29(11):2436. doi: 10.3390/molecules29112436.
2
Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects.瘤内注射编码 survivin 的 mRNA 联合 STAT3 抑制剂 stattic 增强抗肿瘤作用。
Cancer Lett. 2024 Aug 28;598:217111. doi: 10.1016/j.canlet.2024.217111. Epub 2024 Jul 6.
3
Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy.靶向髓系来源抑制细胞增强免疫检查点阻断治疗的抗肿瘤疗效。
Front Immunol. 2021 Dec 22;12:754196. doi: 10.3389/fimmu.2021.754196. eCollection 2021.
4
Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency.可生物降解的中空介孔硅纳米粒子用于调节肿瘤微环境和增强抗肿瘤效率。
Theranostics. 2017 Jul 23;7(13):3276-3292. doi: 10.7150/thno.19987. eCollection 2017.
5
Targeting myeloid-derived suppressive cells in the tumor microenvironment to enhance the efficacy of cancer immunotherapy.靶向肿瘤微环境中的髓系来源抑制细胞以增强癌症免疫治疗的疗效。
Discov Med. 2020 Nov-Dec;30(161):119-128.
6
Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.靶向肿瘤微环境中髓源抑制细胞(MDSCs)的免疫疗法
Front Immunol. 2021 Feb 4;11:585214. doi: 10.3389/fimmu.2020.585214. eCollection 2020.
7
Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.表面功能化介孔二氧化硅纳米粒子作为表柔比星递送至癌细胞的有效载体。
Eur J Pharm Biopharm. 2015 Jan;89:248-58. doi: 10.1016/j.ejpb.2014.12.009. Epub 2014 Dec 13.
8
STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.STING 激活剂 c-di-GMP 负载介孔硅纳米颗粒增强乳腺癌免疫治疗。
ACS Appl Mater Interfaces. 2020 Dec 23;12(51):56741-56752. doi: 10.1021/acsami.0c16728. Epub 2020 Dec 11.
9
Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy.丙戊酸阻断髓源性抑制细胞功能增强抗 PD-L1 肿瘤免疫治疗。
Biochem Biophys Res Commun. 2020 Feb 12;522(3):604-611. doi: 10.1016/j.bbrc.2019.11.155. Epub 2019 Nov 28.
10
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.抑制髓源抑制性细胞的迁移可增强 T 细胞免疫治疗。
JCI Insight. 2019 Apr 4;4(7). doi: 10.1172/jci.insight.126853.

引用本文的文献

1
Nano particle loaded EZH2 inhibitors: Increased efficiency and reduced toxicity for malignant solid tumors.负载纳米颗粒的EZH2抑制剂:提高恶性实体瘤的治疗效率并降低毒性
J Transl Int Med. 2025 May 8;13(2):156-169. doi: 10.1515/jtim-2025-0020. eCollection 2025 Apr.
2
Nanoimmunotherapy: the smart trooper for cancer therapy.纳米免疫疗法:癌症治疗的智能勇士。
Explor Target Antitumor Ther. 2025 Apr 10;6:1002308. doi: 10.37349/etat.2025.1002308. eCollection 2025.
3
Adhesin Antibody-Grafted Mesoporous Silica Nanoparticles Suppress Immune Escape for Treatment of Fungal Systemic Infection.

本文引用的文献

1
Recent applications of immunomodulatory biomaterials for disease immunotherapy.免疫调节生物材料在疾病免疫治疗中的最新应用。
Exploration (Beijing). 2022 May 23;2(6):20210157. doi: 10.1002/EXP.20210157. eCollection 2022 Dec.
2
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
Immune checkpoint blockade in melanoma: Advantages, shortcomings and emerging roles of the nanoparticles.黑色素瘤中的免疫检查点阻断:纳米颗粒的优势、缺点及新兴作用
黏附素抗体接枝介孔硅纳米粒子抑制免疫逃逸用于治疗真菌系统性感染。
Molecules. 2024 Sep 25;29(19):4547. doi: 10.3390/molecules29194547.
Int Immunopharmacol. 2022 Dec;113(Pt A):109300. doi: 10.1016/j.intimp.2022.109300. Epub 2022 Oct 17.
4
Immunotherapy: Reshape the Tumor Immune Microenvironment.免疫疗法:重塑肿瘤免疫微环境。
Front Immunol. 2022 Jul 6;13:844142. doi: 10.3389/fimmu.2022.844142. eCollection 2022.
5
STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice.STAT3 抑制剂 Napabucasin 可消除 MDSC 的免疫抑制能力并延长荷瘤小鼠的生存期。
J Immunother Cancer. 2022 Mar;10(3). doi: 10.1136/jitc-2021-004384.
6
Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy.通过拮抗CXCR2抑制髓源性抑制细胞向肿瘤微环境募集以增强免疫治疗疗效
Cancers (Basel). 2021 Dec 15;13(24):6293. doi: 10.3390/cancers13246293.
7
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment.肿瘤微环境中的髓源性抑制细胞(MDSCs)通过复杂的代谢网络发挥免疫抑制功能。
Cells. 2021 Oct 9;10(10):2700. doi: 10.3390/cells10102700.
8
Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects.癌症免疫治疗中靶向髓源性抑制细胞进行免疫检查点阻断:当前进展与新前景
Clin Med Insights Oncol. 2021 Aug 5;15:11795549211035540. doi: 10.1177/11795549211035540. eCollection 2021.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment.免疫细胞和细胞因子对肿瘤微环境中炎症和免疫抑制的影响。
Int Immunopharmacol. 2020 Nov;88:106939. doi: 10.1016/j.intimp.2020.106939. Epub 2020 Sep 22.